Andresen D - Search Results

1

Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial.

Apostolakis S, Haeusler KG, Oeff M, Treszl A, Andresen D, Borggrefe M, Lip GY, Meinertz T, Parade U, Samol A, Steinbeck G, Wegscheider K, Breithardt G, Kirchhof P. Apostolakis S, et al. Among authors: andresen d. Int J Cardiol. 2013 Oct 9;168(4):3977-81. doi: 10.1016/j.ijcard.2013.06.090. Epub 2013 Jul 18. Int J Cardiol. 2013. PMID: 23871349 Clinical Trial.

2

A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias.

Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffmann E, von Leitner ER. Steinbeck G, et al. Among authors: andresen d. N Engl J Med. 1992 Oct 1;327(14):987-92. doi: 10.1056/NEJM199210013271404. N Engl J Med. 1992. PMID: 1355595 Free article. Clinical Trial.

3

Prognosis of patients with sustained ventricular tachycardia and of survivors of cardiac arrest not inducible by programmed stimulation.

Andresen D, Steinbeck G, Brüggemann T, Haberl R, Fink L, Schröder R. Andresen D, et al. Am J Cardiol. 1992 Nov 15;70(15):1250-4. doi: 10.1016/0002-9149(92)90757-p. Am J Cardiol. 1992. PMID: 1442574

4

[Are anti-arrhythmia agents superior to a beta blocker in treating life-threatening ventricular arrhythmias? Preliminary results of a controlled study].

Steinbeck G, Andresen D, von Leitner ER. Steinbeck G, et al. Among authors: andresen d. Z Kardiol. 1986;75 Suppl 5:47-55. Z Kardiol. 1986. PMID: 2435071 Clinical Trial. German.

5

Control of antiarrhythmic drug therapy by electrophysiologic testing.

Steinbeck G, Lüderitz B, Andresen D. Steinbeck G, et al. Among authors: andresen d. Eur Heart J. 1989 Sep;10 Suppl E:61-5. doi: 10.1093/eurheartj/10.suppl_e.61. Eur Heart J. 1989. PMID: 2680504 Review.

6

New method for the assessment of drug-induced arrhythmia aggravation.

Andresen D, Wegscheider K, Von Leitner ER, Schröder R. Andresen D, et al. Am J Cardiol. 1988 Nov 1;62(13):966-8. doi: 10.1016/0002-9149(88)90904-6. Am J Cardiol. 1988. PMID: 3177242 No abstract available.

7

Risk stratification following myocardial infarction in the thrombolytic era: a two-step strategy using noninvasive and invasive methods.

Andresen D, Steinbeck G, Brüggemann T, Müller D, Haberl R, Behrens S, Hoffmann E, Wegscheider K, Dissmann R, Ehlers HC. Andresen D, et al. J Am Coll Cardiol. 1999 Jan;33(1):131-8. doi: 10.1016/s0735-1097(98)00516-6. J Am Coll Cardiol. 1999. PMID: 9935019 Free article.

8

Immediate Risk-Stratification Improves Survival (IRIS): study protocol.

Steinbeck G, Andresen D, Senges J, Hoffmann E, Seidl K, Brachmann J; IRIS Investigators as Joint Study of the German University Hospitals and German Society of Leading Cardiological Hospital Physicians (ALKK). Steinbeck G, et al. Among authors: andresen d. Europace. 2004 Sep;6(5):392-9. doi: 10.1016/j.eupc.2004.04.008. Europace. 2004. PMID: 15294263

9

Implantable cardioverter-defibrillator therapy after myocardial infarction.

Steinbeck G, Andresen D, Senges J. Steinbeck G, et al. Among authors: andresen d. N Engl J Med. 2005 Mar 10;352(10):1039-41; author reply 1039-41. N Engl J Med. 2005. PMID: 15761994 No abstract available.

10

Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.

Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, Cobbe S, Breithardt G, Le Heuzey JY, Prins MH, Lévy S, Crijns HJ; European Heart Survey Investigators. Nieuwlaat R, et al. Among authors: andresen d. Eur Heart J. 2005 Nov;26(22):2422-34. doi: 10.1093/eurheartj/ehi505. Epub 2005 Oct 4. Eur Heart J. 2005. PMID: 16204266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page